ARIZ Precision Medicine is a company focused on developing cancer treatments using a combination of biological and nanotechnologies. The company aims to stop cancer at its root cause, preventing cancer growth and metastasis.

ARIZ Precision Medicine

ARIZ Precision Medicine is pre-clinical stage company aiming to selectively target and destroy early-stage drivers of cancer, such as the deregulated PRDM genes and proteins that were previously deemed “undruggable”.  ARIZ set out to prove that cancer cells with PRDM abnormalities could be individually targeted and destroyed without harming normal cells by utilizing knowledge of the PRDM gene family, proprietary siRNA constructs and innovative drug delivery nanotechnologies to target these cancer cells. Proof of principle studies confirmed that this approach selectively killed multiple types of cancer cells (breast, colon, lung, myeloma, etc.) thus ARIZ is continuing in the development of new drug candidates for cancer by pushing these products to testing in animal models of cancer. This will give ARIZ compelling data and intellectual property to share with pharmaceutical companies and, thus, enter into strategic partnerships to take our products to the clinic and then to market. Ultimately, through these efforts, ARIZ intends to cure cancers in a way that preserves a patient’s quality of life and avoids the harmful and adverse effects of current therapies. ARIZ is located in Davis, California and benefits from the combined knowledge of a board of experts in PRDM genes, drug delivery and drug development.

Moneta Ventures

Sacramento Angels

I will be speaking at RNA Leaders USA, taking place on September 4-5, 2024. Join me to accelerate innovation and commercialisation of #RNA therapeutics and vaccines #RNALeaders https://lnkd.in/gXaKFy2C RNA Leaders

ARIZ issued a press release proudly announcing the granting of our foundational patent by the USPTO for our siRNA-based therapeutic for lung and other cancers. Many thanks to Maya Skubatch and the team at Wilson Sonsini Goodrich & Rosati

https://lnkd.in/gA8srKQn

Proud to announce that ARIZ Precision Medicine has been selected as a Backyards Award finalist in the "Breakthrough Innovation" category.  Winners will be announced during the GFX2023 conference on October 5th.  Thanks so much to Growth Factory and Stoel Rives LLP!  Join us on the 5th to hear about our progress in developing a precision-based therapeutic for lung cancer.

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

company_structure

crunchbase_trigger

crunchbase_profile

li_profile

translate_crunchbase_fundingrounds

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	Aug 31, 2024 6:43 AM	814761fc
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Aug 31, 2024 6:43 AM	108d1a8c
translate crunchbase fundingrounds	general
peers	general	Aug 31, 2024 6:43 AM	d09bad06
news basic	general	Aug 31, 2024 6:43 AM	3d609103
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
company structure	company_analysis
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

ARIZ

COM:ARIZBIO

ARIZ Precision Medicine